These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20102632)

  • 1. Evaluation of adenovirus capsid labeling versus transgene expression.
    Li J; Fatima A; Komarova S; Ugai H; Uprety P; Roth JC; Wang M; Oster RA; Curiel DT; Matthews QL
    Virol J; 2010 Jan; 7():21. PubMed ID: 20102632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
    Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
    Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.
    Vellinga J; Rabelink MJ; Cramer SJ; van den Wollenberg DJ; Van der Meulen H; Leppard KN; Fallaux FJ; Hoeben RC
    J Virol; 2004 Apr; 78(7):3470-9. PubMed ID: 15016870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.
    Vellinga J; de Vrij J; Myhre S; Uil T; Martineau P; Lindholm L; Hoeben RC
    Gene Ther; 2007 Apr; 14(8):664-70. PubMed ID: 17268536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
    Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
    Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
    Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.
    Matthews QL
    Mol Pharm; 2011 Feb; 8(1):3-11. PubMed ID: 21047139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.
    Mathis JM; Bhatia S; Khandelwal A; Kovesdi I; Lokitz SJ; Odaka Y; Takalkar AM; Terry T; Curiel DT
    PLoS One; 2011 Feb; 6(2):e16792. PubMed ID: 21347423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
    Li J; Le L; Sibley DA; Mathis JM; Curiel DT
    Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.
    Pereboeva L; Komarova S; Mahasreshti PJ; Curiel DT
    Virus Res; 2004 Sep; 105(1):35-46. PubMed ID: 15325079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
    Kojima H; Ohishi N; Yagi K
    Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent and Bioluminescent Reporter Myxoviruses.
    Rostad CA; Currier MC; Moore ML
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27527209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
    Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
    Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent biodistribution and transgene expression of a recombinant human adenovirus serotype 5-luciferase vector as a surrogate for rAd5-FMDV vaccines in cattle.
    Montiel NA; Smoliga G; Arzt J
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):37-48. PubMed ID: 23219159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.